FDA Investigator LCDR Jennifer H Rhyu

LCDR Jennifer H Rhyu has inspections in 3 countries as of 16 Oct 2023. LCDR Jennifer H Rhyu has collaborated with a combinined 4294 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
117
Last Inspection Date:
16 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100004532
Country:
United States of America, India, China
Co-Investigator(s):
Aaron G Pang, Adam S Freeman, Alex G Kalugin, Alexandra M Cossi, Alice A Blair, Alicia K Mckinsey, Alison A Nicoli, Alla Dubrovsky, Amanda B Athey, Andrea A Branche, Andrea George, PhD, Andrew B Slarve, Andrew T Todd, Andrew Tadros, Angel K Sandhu, Anh M Lac, Anthony E Keller, RPh, Arindam Dasgupta, PhD, Ashar P Parikh, Ashley A Mutawakkil, Barbara J Arrais, Barbara J Wilcox, PhD, Bradley J Maunder, Breena L D'ambrogi, Brett W Podoski, Bruce D Broidy, Bryce A May, Byungja E Marciante, Calvin B Koerner, Capri R Woolridge, Carl Lee, Carole L Jones, Carr, CDR Rochelle B Young, RPh, MSA, Chloe Anne K Le, Chloe Anne Leong, Christine M Parmentier, Christopher R Czajka, Courtney R Bolton, Courtney R Warren, Damon A Growl, Daniel C Geffin, Daniel J Roberts, David A Lum, David G Eng, Deborah K Richardson, Deborah Kleinfeld, Debra D Devlieger, Diane Cvan Leeuwen, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edna J Hidalgo, Eileen A Liu, Elaine S Chow, Emily Shacter, Eric C Nielsen, Eric J Heinze, Eric L Dong, BS, Eric W Anderson, Erica L Nicoll, Erica R Pomeroy, Estefania Fernandez, Frank P Bianco, Gavin W Pierce, Gerald Feldman, Gerald M Feldman, PhD, Gina M Hall, Glen E Harelson, Helen J Hamaoka, Helen J Mamaoka, Henry K Lau, Henry X Lau, Herbert E Arden, Hoimay Chan, Humberto Z Gomez, Huy T Pham, Ingrid A Zambrana, Ismael Garibay, James C Lee, PharmD, James C Yee, James R Evans, Janice R Small, Janice Wai, Jeanne A Young, Jeanne Fringer, PhD, Jeffrey M Watson, Jenniefer N Ruyu, Jennifer A Hickey, Jennifer L Degroot, Jennifer L Johnson, Joan T Briones, Joanna M Fukuda, Joanne M Fukuda, Jocelyn T Ramos, John A Gonzalez, John A Liu, John Cook, Jolanna A Norton, Jolene S Hedgecock, Jose E Melendez, DDC, Joseph A Seitz, Joseph Kutze, PhD, Joseph M Willems, Joseph P Iser, MD, Joshua S Hunt, Juan A Morales, Jude C Dikes, Judy Ellen Ciaraldi, Juliane Kjung Lau, Karen D Phung, Karen J Bak, Karen M Willis, Kawshalya Pathiraja, Keegan B Mixon, Kenneth O Gee, PhD, Kenneth S Boehnen, Keren Arkin, Kevin P Foley, Kim Lthomas Cruse, Kimberly A Joseph, Kristin M Abaonza, Lakisha M Williams, Lance M De Souza, MBA, Larkin R Buckalew, Lauren M Lilly, PhD, Laurie P Norwood, Laverne Puckett, Lee, Leongc, Ligia M Sanders, Lillian C Lopez, Linda J Cruz, Linda Linh T Nguyen, Linda S Shook, Linda Thai, Linh Tu, Lisa H Nakagawa, Lisa Shin, Lucila B Nwatu, Lydia S Chan, Lynda L Perry, PhD, Lynn L Wong, Mabel M Lee, Macropolk, Maida Henesian (NMI), Maridali De Leon Torres, Marie K Kinkade, Mariza M Jafary, Mark E Chan, Mark I Nakano, Mark W Babbitt, Marsha W Major, Mary C Acton, Mary Ewilkerson Brinsko, Mary K Kinkade, Mary T Carden, Matthew C Johns, Matthew K Wong, Megan E Kulas, Melissa N Simanton, Melody M Ragasa Leong, Michael Davila, Michael L Myers, Michael Shanks, MS, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanma Liu, Monique C Lo, Nayan J Patel, Nayan Patel, Nicholas L Hunt, Nicholas M Smith, Nicholas Obiri, PhD, Nicole Yuen, Nympha V Florendo, Omotunde O Osunsanmi, Paula E Davis Debella, Peter E Baker, Peter Kessler, PhD, Phung, Quynh H Strandberg, Randall F Albright, Randall J Plunkett, Randall P Zielinski, Ravi S Harapanhalli, Raymond T Oji, Rebecca E Sulpacio, Rebecca Rodriguez, Rebecca T Davis, Richard L Bartlett, Riley C Myers, PhD, Robert D Tollefsen, Roberta K Smith, Roger D Gawne, Rumany C Penn, PharmD, Sandra S Saniga, Sara M Richardson, Scott N Lim, Sean P Desbrow, Serge Beaucage, Sergio Chavez (NMI), Seyyida Saterfield, Sharon K Thoma, PharmD, Sharon K Thomas, Sharon L Shane, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Siobhan A Gallagher, Sripal R Mada, PhD, State Agency, Stephanie A Slater, MS, Stephanie Mangigian, MS/OSH, RN, Steven B Chiu, Steven C Himebaugh, Steven J Branch, Steven M Galvez, Stuart Kim, Stuart W Russell, Suzanne M Healy, Terrence Gee, Terry A Hook, DPh, Thea C Grome, Thomas J Arista, Thomas N Adjabeng, Thuy T Nguyen, LCDR, Timothy C Grome, Travelle D Mason, Travis S Bradley, Truong Xuan Nguyen (Andy), Uduak M Inokon, Victoria L Morgan, Walden H Lee, Wayne L Jefferson, William J Foust, William J Weis, William V Millar, Xikui Chen (nmi), PhD, Yi Wang, PhD, Yvonne C Wilkes, Zachary A Bogorad

LCDR Jennifer H Rhyu's Documents

Publish Date Document Type Title
May, 2013 FDA 483 Franco Felizarta, M.D. - Form 483, 2013-05-24
July, 2014 FDA 483 ASEGUA THERAPEUTICS LLC - Form 483, 2014-07-25
November, 2013 FDA 483 Response Wedgewood Connect, LLC - Form 483R, 2013-11-25
September, 2014 FDA 483 UCSF Home Therapy Services - Form 483, 2014-09-12
August, 2013 FDA 483 Frontage Laboratories (Shanghai) Co., Ltd. - Form 483, 2013-08-09
June, 2010 FDA 483 Comparative Biosciences, Inc - Form 483, 2010-06-23
November, 2013 FDA 483 Wedgewood Connect, LLC - Form 483, 2013-11-05
February, 2014 FDA 483 Genentech, Inc. - Form 483, 2014-02-21
April, 2009 FDA 483 Setton Pistachio of Terra Bella, Inc. - Form 483, 2009-04-30
May, 2014 FDA 483 One Way Drug, LLC - Form 483, 2014-05-30
May, 2013 EIR Franco Felizarta, M.D. - EIR, 2013-05-24
April, 2009 FDA 483 Response Setton Pistachio of Terra Bella, Inc. - Form 483R, 2009-04-30
January, 2014 EIR ASEGUA THERAPEUTICS LLC - EIR, 2014-01-15
January, 2014 FDA 483 ASEGUA THERAPEUTICS LLC - Form 483, 2014-01-15
November, 2013 FDA 483 Leiter’s Compounding - Form 483, 2013-11-05
August, 2013 EIR Frontage Laboratories (Shanghai) Co., Ltd. - EIR, 2013-08-09
July, 2014 EIR ASEGUA THERAPEUTICS LLC - EIR, 2014-07-25
April, 2009 EIR Setton Pistachio of Terra Bella, Inc. - EIR, 2009-04-30
January, 2012 FDA 483 Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. - Form 483, 2012-01-20
August, 2013 FDA 483 WuXi AppTec Co., Ltd. - Form 483, 2013-08-16

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more